Aliskiren
Tekturna, Rasilez (aliskiren) is a small molecule pharmaceutical. Aliskiren was first approved as Tekturna on 2007-03-05. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against renin. Tekturna's patent is valid until 2026-02-19 (FDA).
| Trade Name | Rasilez |
|---|---|
| Common Name | Aliskiren |
| Indication | hypertension |
| Drug Class | Renin inhibitors |
